<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03936751</url>
  </required_header>
  <id_info>
    <org_study_id>SDC 4782/18/148</org_study_id>
    <nct_id>NCT03936751</nct_id>
  </id_info>
  <brief_title>Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY.</brief_title>
  <acronym>CPAP-CARE</acronym>
  <official_title>Impact of Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: a Multicenter Randomized Controlled Study (CPAP-CARE STUDY).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Philips Respironics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the advances in the treatment of acute cardiogenic pulmonary edema (ACPE), the
      readmissions rates and cardiovascular events remain very high. In this context, it is
      possible that other potential risk factors may influence the poor prognosis of the ACPE. One
      of these potential candidates is Obstructive Sleep Apnea(OSA). This study was designed to
      evaluate the impact of OSA treatment with CPAP in consecutive patients with ACPE. The primary
      outcome will be to evaluate the impact of CPAP on the recurrence of ACPE in the 1-year
      follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of ACPE recurrence</measure>
    <time_frame>1-year</time_frame>
    <description>To evaluate the effects of CPAP on the recurrence of ACPE as compared to placebo</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of all-cause mortality</measure>
    <time_frame>1-year</time_frame>
    <description>To evaluate the effects of CPAP on the all-cause mortality as compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of cardiovascular mortality</measure>
    <time_frame>1-year</time_frame>
    <description>To evaluate the effects of CPAP on the cardiovascular mortality as compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of new hospital admissions</measure>
    <time_frame>1-year</time_frame>
    <description>To evaluate the effects of CPAP on the number of new hospital admissions as compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure effects ( (mmHg)</measure>
    <time_frame>1-year</time_frame>
    <description>To evaluate the effects of CPAP on the blood pressure reduction as compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of BNP levels (pg/ml)</measure>
    <time_frame>1-year</time_frame>
    <description>To evaluate the effects of CPAP on the BNP levels as compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac function (left ventricular ejection fraction - %)</measure>
    <time_frame>1-year</time_frame>
    <description>To evaluate the effects of CPAP on the left ventricular ejection fraction (by echocardiography) as compared to placebo</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Pulmonary Edema Cardiac Cause</condition>
  <arm_group>
    <arm_group_label>CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous positive airway pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal strips</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Nasal Strips</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>This is the standard treatment for OSA.</description>
    <arm_group_label>CPAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal Strips</intervention_name>
    <description>Nasal strips were commercially available in the market for supposing treat snoring and sleep apnea but no proof that this is true. Our group previously validated nasal strips as an interesting placebo.</description>
    <arm_group_label>Nasal strips</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypertensive acute Cardiogenic Pulmonary Edema

          -  Moderate to Severe OSA

        Exclusion Criteria:

          -  Professional drivers

          -  Pregnancy

          -  Non-Cardiogenic Pulmonary edema

          -  Terminal cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Luciano F Drager, MD, PhD</last_name>
    <phone>551126615084</phone>
    <email>luciano.drager@incor.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sofia F Furlan, PhD</last_name>
    <email>sofiaffurlan@yahoo.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>PROCAPE - University of Pernambuco</name>
      <address>
        <city>Recife</city>
        <state>Sao Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarcya Couto, PT</last_name>
    </contact>
    <investigator>
      <last_name>Rodrigo P Pedrosa, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart Institute (InCor)</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05049000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofia F Furlan, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Luciano F Drager, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Dante Pazzanese</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adriana Bertolami, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Adriana Bertolami, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 5, 2019</study_first_submitted>
  <study_first_submitted_qc>April 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2019</study_first_posted>
  <last_update_submitted>April 30, 2019</last_update_submitted>
  <last_update_submitted_qc>April 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Luciano F Drager, MD, PhD</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Pulmonary Edema</mesh_term>
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

